actinium has been researched along with Benign Neoplasms, Brain in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Almaguel, FG; Debinski, W; Herpai, DM; Mintz, A; Pandya, DN; Sattiraju, A; Solingapuram Sai, KK; Wadas, TJ; Xuan, A | 1 |
Boshomane, TG; Bruchertseifer, F; Knoesen, O; Lawal, IO; Lengana, T; Mokoala, KK; Morgenstern, A; Sathekge, MM; Vorster, M | 1 |
Behling, K; Gutin, PH; López Puebla, JC; Maguire, WF; McDevitt, MR; O'Donoghue, J; Ruggiero, A; Scheinberg, DA; Sprinkle, SR | 1 |
3 other study(ies) available for actinium and Benign Neoplasms, Brain
Article | Year |
---|---|
IL13RA2 targeted alpha particle therapy against glioblastomas.
Topics: Actinium; Alpha Particles; Animals; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Copper Radioisotopes; Cysteamine; Disease Models, Animal; DNA Breaks, Double-Stranded; Gene Expression; Glioblastoma; Humans; Interleukin-13 Receptor alpha2 Subunit; Isotope Labeling; Male; Mice; Peptides; X-Ray Microtomography; Xenograft Model Antitumor Assays | 2017 |
Treatment of brain metastases of castration-resistant prostate cancer with
Topics: Actinium; Brain Neoplasms; Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals | 2019 |
Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma.
Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Blood Vessels; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Mice; Neoplasm Grading; Radiochemistry; Radioimmunotherapy; Radiotherapy Dosage | 2016 |